0001752724-24-022182.txt : 20240213
0001752724-24-022182.hdr.sgml : 20240213
20240213084733
ACCESSION NUMBER: 0001752724-24-022182
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231130
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
EFFECTIVENESS DATE: 20240213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: VANGUARD NEW YORK TAX-FREE FUNDS
CENTRAL INDEX KEY: 0000788599
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1130
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-04570
FILM NUMBER: 24622788
BUSINESS ADDRESS:
STREET 1: PO BOX 2600
STREET 2: V26
CITY: VALLEY FORGE
STATE: PA
ZIP: 19482
BUSINESS PHONE: 6106691000
MAIL ADDRESS:
STREET 1: PO BOX 2600
STREET 2: V26
CITY: VALLEY FORGE
STATE: PA
ZIP: 19482
FORMER COMPANY:
FORMER CONFORMED NAME: VANGUARD NEW YORK INSURED TAX FREE FUND
DATE OF NAME CHANGE: 19920703
0000788599
S000002905
Vanguard New York Long-Term Tax-Exempt Fund
C000007969
Investor Shares
VNYTX
C000007970
Admiral Shares
VNYUX
0000788599
S000002906
Vanguard New York Municipal Money Market Fund
C000007971
Investor Shares
VYFXX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0000788599
XXXXXXXX
811-04570
true
false
false
N-1A
true
VANGUARD NEW YORK TAX-FREE FUNDS
811-04570
0000788599
549300IVPEPO12W2EL28
100 VANGUARD BOULEVARD
MALVERN
19355
US-PA
US
6106691000
State Street Bank and Trust
One Congress Street, Suite 1
Boston
20114
617-662-3839
The accounts, books, and other documents required to be maintained by Registrant pursuant to section 31(a) of the Investment Company Act of 1940 and the Rules thereunder.
N
N
N-1A
2
Y
David Thomas
N/A
N
Mortimer J. Buckley
002167630
Y
Andre F. Perold
N/A
N
Deanna Mulligan
N/A
N
Grant Reid
N/A
N
Peter F. Volanakis
N/A
N
Mark Loughridge
N/A
N
Emerson U. Fullwood
N/A
N
Sarah Bloom Raskin
N/A
N
Tara Bunch
N/A
N
F. Joseph Loughrey
N/A
N
Scott C. Malpass
N/A
N
Jacqueline Angell
005606776
100 Vanguard Boulevard
Malvern
19355
XXXXXX
N
N
N
N
N
N
VANGUARD MARKETING CORP.
8-21570
000007452
N/A
Y
N
PRICEWATERHOUSECOOPERS LLP
000000238
5493002GVO7EO8RNNS37
N
N
N
N
N
N
N
VANGUARD NEW YORK LONG-TERM TAX-EXEMPT FUND
S000002905
9X54UMZHJBMD08GNDG54
N
2
0
0
N/A
Y
N
N
N
N/A
N/A
N/A
Rule 32a-4 (17 CFR 270.32a-4)
Rule 18f-4(f)(17 CFR 270.18f-4(f))
Rule 17a-7 (17 CFR 270.17a-7)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
N
N
N
N
The Vanguard Group, Inc.
801-11953
000105958
5493002789CX3L0CJP65
N
The Vanguard Group, Inc.
084-00772
5493002789CX3L0CJP65
Y
N
N
Markit North America INC
13-4153988
TIN
N
Markit Group Limited
549300HLPTRASHS0E726
GB
N
ICE Data Pricing and Reference Data LLC
13-36687789
TIN
N
JPMorgan Chase Bank
7H6GLXDRUGQFU57RNE97
N
Bloomberg Finance LP
5493001KJTIIGC8Y1R12
N
Refinitiv US LLC
20-4530702
TIN
N
ITG Analytics Inc
41-2190282
TIN
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Vanguard Group, Inc.
5493002789CX3L0CJP65
Y
N
N
STATE STREET BANK AND TRUST
571474TGEMMWANRLN572
N
Y
THE VANGUARD GROUP, INC.
5493002789CX3L0CJP65
Y
N
N
0.00000000
Wells Fargo Securities, LLC
008-22947
000007665
VYVVCKR63DVZZN70PB21
328222464.34999990
Barclays Capital Inc.
008-41342
000019714
AC28XWWI3WIBK2824319
1645086252.67000010
BofA Securities, Inc.
008-69787
000283942
549300HN4UKV1E2R3U73
751928243.80999982
U.S. Bancorp
008-35359
000017868
N1GZ7BBF3NP8GI976H15
521970000.00000000
Morgan Stanley & Co. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
393196095.04000002
J.P. Morgan Securities LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
1501207935.01999990
TD Securities (USA) LLC
008-36747
000018476
SUVUFHICNZMP2WKHG940
255886580.55000001
Goldman Sachs & Co. LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
377508369.45999998
UBS Securities LLC
008-22651
000007654
T6FIZBDPKLYJKFCRVK44
444552470.94999999
Jefferies LLC
008-15074
000002347
58PU97L1C0WSRCWADL48
494854953.90999997
8133758875.82999960
N
4265864747.61833333
Committed
4300000000.00000000
N
N
N
N
VANGUARD NEW YORK MUNICIPAL MONEY MARKET FUND
S000002906
G4528JUXYSF6QL6F4092
N
1
0
0
Money Market Fund
Y
N
N
N
N/A
N/A
N/A
Rule 18f-4(f)(17 CFR 270.18f-4(f))
Rule 32a-4 (17 CFR 270.32a-4)
Rule 17a-7 (17 CFR 270.17a-7)
Y
N
N
N
The Vanguard Group, Inc.
801-11953
000105958
5493002789CX3L0CJP65
N
The Vanguard Group, Inc.
084-00772
5493002789CX3L0CJP65
Y
N
N
Markit North America INC
13-4153988
TIN
N
ICE Data Pricing and Reference Data LLC
13-36687789
TIN
N
Refinitiv US LLC
20-4530702
TIN
N
ITG Analytics Inc
41-2190282
TIN
N
Bloomberg Finance LP
5493001KJTIIGC8Y1R12
N
Markit Group Limited
549300HLPTRASHS0E726
GB
N
JPMorgan Chase Bank
7H6GLXDRUGQFU57RNE97
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
The Vanguard Group, Inc.
5493002789CX3L0CJP65
Y
N
N
STATE STREET BANK AND TRUST
571474TGEMMWANRLN572
N
Y
THE VANGUARD GROUP, INC.
5493002789CX3L0CJP65
Y
N
N
0.00000000
Piper Sandler & Co.
008-15204
000000665
549300GRQCWQ3XGH0H10
171260000.00000000
RBC Capital Markets, LLC
008-45411
000031194
549300LCO2FLSSVFFR64
205045000.00000000
Morgan Stanley & Co. LLC
008-15869
000008209
9R7GPTSO7KV3UQJZQ078
424250000.00000000
TD Securities (USA) LLC
008-36747
000018476
SUVUFHICNZMP2WKHG940
333575000.00000000
U.S. Bancorp
008-35359
000017868
N1GZ7BBF3NP8GI976H15
626815000.00000000
CITIGROUP INC.
N/A
N/A
6SHGI4ZSSLCXXQSBB395
304340000.00000000
J.P. Morgan Securities LLC
008-35008
000000079
ZBUT11V806EZRVTWT807
1326638561.76000000
Goldman Sachs & Co. LLC
008-00129
000000361
FOR8UP27PHTHYVLBNG30
310007000.00000000
Jefferies LLC
008-15074
000002347
58PU97L1C0WSRCWADL48
245630000.00000000
BofA Securities, Inc.
008-69787
000283942
549300HN4UKV1E2R3U73
827694000.00000000
5453256578.26000000
N
2591096949.29824701
Committed
4300000000.00000000
N
N
N
true
INTERNAL CONTROL RPT
2
newyorktaxfreefunds11.30.txt
Report of Independent Registered Public
Accounting Firm
To the Board of Trustees of Vanguard New York
Tax-Free Funds and Shareholders of
Vanguard New York Long-Term Tax-Exempt Fund
and
Vanguard New York Municipal Money Market Fund
In planning and performing our audits of the financial
statements of Vanguard New York Long-Term Tax-
Exempt Fund and Vanguard New York Municipal
Money Market Fund (constituting Vanguard New
York Tax-Free Funds, hereafter collectively referred
to as the "Funds") as of and for the year ended
November 30, 2023, in accordance with the
standards of the Public Company Accounting
Oversight Board (United States) (PCAOB), we
considered the Funds' internal control over financial
reporting, including controls over safeguarding
securities, as a basis for designing our auditing
procedures for the purpose of expressing our
opinion on the financial statements and to comply
with the requirements of Form N-CEN, but not for
the purpose of expressing an opinion on the
effectiveness of the Funds' internal control over
financial reporting. Accordingly, we do not express
an opinion on the effectiveness of the Funds' internal
control over financial reporting.
The management of the Funds is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling this
responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A company's
internal control over financial reporting is a process
designed to provide reasonable assurance regarding
the reliability of financial reporting and the
preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles. A company's internal control
over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and
fairly reflect the transactions and dispositions of the
assets of the company; (2) provide reasonable
assurance that transactions are recorded as
necessary to permit preparation of financial
statements in accordance with generally accepted
accounting principles, and that receipts and
expenditures of the company are being made only in
accordance with authorizations of management and
directors of the company; and (3) provide
reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or
disposition of a company's assets that could have a
material effect on the financial statements.
Because of its inherent limitations, internal control
over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk
that controls may become inadequate because of
changes in conditions, or that the degree of
compliance with the policies or procedures may
deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees,
in the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency, or
a combination of deficiencies, in internal control over
financial reporting, such that there is a reasonable
possibility that a material misstatement of the
company's annual or interim financial statements will
not be prevented or detected on a timely basis.
Our consideration of the Funds' internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control over financial reporting that might be material
weaknesses under standards established by the
PCAOB. However, we noted no deficiencies in the
Funds' internal control over financial reporting and
its operation, including controls over safeguarding
securities, that we consider to be a material
weakness as defined above as of November 30,
2023.
This report is intended solely for the information and
use of the Board of Trustees of Vanguard New York
Tax-Free Funds and the Securities and Exchange
Commission and is not intended to be and should
not be used by anyone other than these specified
parties.
/s/PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
January 19, 2024
1